StockNow
Log in
Global Markets

Additional European Equity News

News detail

AstraZeneca (AZN LN) - Co. announced that the MULBERRY Phase III randomised, placebo-controlled trial in children with HPP who have not been previously treated with Strensiq, showed efzimfotase alfa demonstrated statistically significant and clinically meaningful improvement in bone health. (AstraZeneca) Getlink (GET FP) - Mundys confirms it has raised its stake to 9.5%. Mundys will hold 19.0% of Getlink’s share capital and up to 24.9% of its voting rights confirming itself as one of the main shareholders of the company. (Getlink)

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)